Associate Chief of Staff for Education & Research West Palm Beach VA Healthcare System University of Miami, Nova Southeastern University, Florida Atlantic University Riviera Beach, Florida
Pain associated with Diabetic Peripheral Neuropathy is a highly prevalent condition that can be very disabling and difficult to manage. Proven effective treatments only help some patients with the condition and management recommendations have significantly evolved over the last 20 years based on newer available agents and ever-evolving medical evidence showing efficacy of some agents and lack of efficacy of others, challenging traditional paradigms. State-of-the-art assessment (including demostration of key aspects of the physical exam) and important associated comorbidities will be discussed. The evolution of several clinical practice guidelines and its medical evidence will be presented for various pharmacotherapy options. Non-pharmacological options, including newer and emerging minimally-invasive treatment options will also be discussed. Finally, practical management algorithms, including mechanistic approaches, will be appraised based on various factors such as medical comorbidities, cost, and patient response.
This session is sponsored by an educational grant from Averitas Pharma, Inc.
Learning Objectives:
Increase knowledge regarding the Etiology and pathophysiology of diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy (PDN)
Increase knowledge regarding the Long-term morbidity associated with DPN and PDN
Increase knowledge regarding the Signs and symptoms of DPN and PDN
Increase confidence in their ability to recognize signs and symptoms of DPN and PDN in clinical practice
Increase confidence in their ability to select treatment and management options for DPN and PDN